Rocket Lab Corp is engaged in space, building rockets, and spacecraft... Show more
Rocket Lab is one of the few vertically integrated, end-to-end space companies, operating across both launch services and space systems. Its Electron rocket is the most frequently launched small-lift orbital vehicle in the United States, giving the company a proven operational track record that analysts cite as a structural advantage. The space systems segment has become the dominant revenue driver, expanding 88% year-over-year in the latest quarter and providing diversification beyond launch.
The medium-term thesis hinges on Neutron, a reusable medium-lift rocket designed to carry up to 13,000 kilograms to low Earth orbit. Neutron would expand Rocket Lab's addressable market from small satellites into larger commercial, constellation, and national-security missions, positioning it more directly against SpaceX's Falcon 9. Management has outlined a long-term goal of roughly $1 billion in Neutron revenue within three to five years and a non-GAAP gross margin target above 50%, supported by reusability and higher launch cadence. Structurally, the company's backlog of 117 launches and more than 55 spacecraft in development underscores demand, though the path to profitability still depends heavily on Neutron execution and the timing of the Iridium integration.
The most consequential near-term catalyst is Neutron's first launch. After discovering composite voids in the first-stage tank's forward dome, Rocket Lab pushed the maiden flight to no earlier than 2027 and has not committed to a firm date. Investors are watching first-quarter 2027 hydrostatic and cryogenic tank tests as the next verifiable milestone; a passed test and confirmed launch date would likely be viewed as de-risking events. Management has said a successful test flight could move the company toward positive adjusted EBITDA the following quarter.
The Iridium acquisition is the second major catalyst. With Iridium shareholders having approved the deal and financing completed through an equity offering, the remaining hurdle is regulatory approval, with closing expected around mid-2027. The transaction would roughly double Rocket Lab's size and add recurring satellite-services cash flow.
Other catalysts include the fourth-quarter earnings report, continued backlog conversion, and a $150 million conditional loan commitment from the Department of War's Office of Strategic Capital aimed at expanding manufacturing and launch turnaround capacity. On the analyst front, sentiment has become more mixed: Clear Street raised its target to $110, while Piper Sandler cut its rating to Neutral with a $58 target, Barclays trimmed to $82, and Cantor Fitzgerald lowered to $111 — reflecting both demand strength and Neutron-related uncertainty.
Rocket Lab operates in a space economy shaped by rising government defense budgets, growing commercial satellite constellations, and constrained launch supply. Tight capacity is a structural tailwind that has allowed the company to raise Neutron pricing before its first flight. Geopolitical tensions are reinforcing national-security demand, while commercial operators are booking launch slots into the 2030s.
On the macro side, interest rates and financing conditions matter for a company that is not yet GAAP-profitable and has funded its Iridium acquisition partly through equity. Higher rates raise the cost of capital and can pressure valuations of high-growth, cash-burning companies. Inflation and supply-chain costs also affect manufacturing margins, although the company's launch-cost-per-mission has been trending lower. Regulatory approval of the Iridium deal remains a key policy variable, and any shifts in government space procurement could directly influence the revenue pipeline.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users identify developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad universe of tradable instruments. The product offers searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For investors tracking a catalyst-heavy name like Rocket Lab, monitoring trend signals alongside fundamental developments can provide additional perspective.
Heading into the remainder of 2026 and through 2027, Rocket Lab's trajectory will be defined by its transition from a small-launch specialist into a full-spectrum space company. The successful commercialization of Neutron is the linchpin: it would unlock larger missions, support higher cadence, and, with component reuse, help drive margins toward management's long-term targets. The Iridium integration, if completed, would layer recurring satellite-services revenue onto the launch and space-systems businesses, improving the margin mix and cash-flow profile.
Long-term, the company is also building a defense prime identity, with contracts such as the Space Development Agency award and a growing spacecraft pipeline. Consensus estimates suggest Rocket Lab could approach revenue of roughly $1.36 billion in fiscal 2027, with earnings near breakeven, though these figures remain dependent on Neutron's timeline. Morgan Stanley, which maintains an Overweight rating and $103 price target, projects about $3.11 billion in revenue and $943 million in adjusted EBITDA for 2030 — figures that reflect the Street's view of the company's long-term earnings power rather than near-term results.
The principal risks are execution risk on Neutron, continued cash burn from research and development, integration risk from the Iridium deal, and potential dilution. How the company navigates these will determine whether it can convert an exceptional backlog into sustainable profitability.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, RKLB has been closely correlated with LUNR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RKLB jumps, then LUNR could also see price increases.
| Ticker / NAME | Correlation To RKLB | 1D Price Change % | ||
|---|---|---|---|---|
| RKLB | 100% | +6.54% | ||
| LUNR - RKLB | 79% Closely correlated | -1.91% | ||
| FLY - RKLB | 78% Closely correlated | -2.51% | ||
| VOYG - RKLB | 72% Closely correlated | +4.01% | ||
| PL - RKLB | 68% Closely correlated | -0.70% | ||
| SATL - RKLB | 62% Loosely correlated | -1.64% | ||
More | ||||
Industry AerospaceDefense
The RSI Oscillator for RKLB moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 30 of the 32 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on RKLB as a result. In 81 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for RKLB just turned positive on November 09, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in 40 of 43 cases over the following month. The odds of a continued upward trend are 90%.
RKLB moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +18.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 265 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for RKLB entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.717) is normal, around the industry mean (5.050). RKLB's P/E Ratio (-196.556) is considerably lower than the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.367).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.